Young women with atypical endometrial hyperplasia or endometrial adenocarcinoma stage I: Will conservative treatment allow pregnancy? Results of a French multicentric survey;Hyperplasies atypiques et carcinomes de l'endomètre de stade I chez la femme jeune désirant une grossesse: Le traitement conservateur est-il envisageable? Résultats d'une étude multicentrique française

Gynecologie Obstetrique et Fertilite

Volumn 34, Issue 1, 2006, Pages 27-33

  Le Digabel, J F ^a   Gariel, C ^b   Catala, L ^a   Dhainaut, C ^b   Madelenat, P ^b   Descamps, P ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Atypical endometrial hyperplasia; Conservative treatment; Endometrial carcinoma; Pregnancy

Indexed keywords

GESTAGEN;

ADULT; CANCER REGRESSION; CHILDBIRTH; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DELIVERY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FRENCH GUIANA; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; INFERTILITY; PREGNANCY; RETROSPECTIVE STUDY; REVIEW;

EID: 31944446236     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2005.11.005     Document Type: Article

References (25)

1. R.L. Kempson, and G.E. Pokorny Adenocarcinoma of the endometrium in women aged forty and younger Cancer 21 4 1968 650 662
2. R. Kimmig, T. Strowitzki, J. Muller-Hocker, R. Kurzl, M. Korell, and H. Hepp Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy Gynecol. Oncol. 58 2 1995 255 257
3. R.J. Kurman, P.F. Kaminski, and H.J. Norris The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients Cancer 56 2 1985 403 412
4. J.G. Thornton, L.A. Brown, and M. Wells Primary treatment of endometrial cancer with progestagen alone Lancet 2 8448 1985 207 208
5. M. Imai, T. Jobo, R. Sato, M. Kawaguchi, and H. Kuramoto Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations Eur. J. Gynaecol. Oncol. 22 3 2001 217 220
6. P. Jadoul, and J. Donnez Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma Fertil. Steril. 80 6 2003 1315 1324
7. C.B. Wang, C.J. Wang, and H.J. Huang Fertility-preserving treatment in young patients with endometrial adenocarcinoma Cancer 94 8 2002 2192 2198
8. T.C. Randall, and R.J. Kurman Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 Obstet. Gynecol. 90 3 1997 434 440
9. T. Kaku, H. Yoshikawa, and H. Tsuda Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome Cancer Lett. 167 1 2001 39 48
10. J.V. Bokhman, O.F. Chepick, A.T. Volkova, and A.S. Vishnevsky Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol. Oncol. 20 2 1985 139 155
11. K. Ushijima, T. Kamura, and H. Yoshikawa Fertility-sparing treatment by high dose oral medroxyprogesterone acetate for endometrial cancer and atypical hyperplasia in young women: a multicentric phase II study Proc. Am. Soc. Clin. Oncol. 23 2005 460s (Abstract 5022)
12. J.T. Thigpen, M.F. Brady, and R.D. Alvarez Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group J. Clin. Oncol. 17 6 1999 1736 1744
13. D.P. Schammel, K.R. Mittal, K. Kaplan, L. Deligdisch, and F.A. Tavassoli Endometrial adenocarcinoma associated with intrauterine pregnancy. A report of five cases and a review of the literature Int. J. Gynecol. Pathol. 17 4 1998 327 335
14. C. Yazbeck, C. Dhainaut, A. Thoury, P. Driguez, and P. Madelenat Taitement conservateur du cancer et des hyperplasies atypiques de l'endom̀tre Gynecol. Obstet. Fertil. 32 5 2004 433 441
15. Y.B. Kim, C.H. Holschneider, K. Ghosh, R.K. Nieberg, and F.J. Montz Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature Cancer 79 2 1997 320 327
16. N. Takeshima, H. Nishida, T. Tabata, Y. Hirai, and K. Hasumi Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators Gynecol. Oncol. 82 3 2001 470 473
17. P.T. Soliman, J.C. Oh, and K.M. Schmeler Risk factors for young premenopausal women with endometrial cancer Obstet. Gynecol. 105 3 2005 575 580
18. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 8 Suppl 1987 2035 2041
19. N. Takeshima, Y. Hirai, N. Tanaka, T. Yamawaki, K. Yamauchi, and K. Hasumi Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion Obstet. Gynecol. 88 2 1996 280 282
20. S.Y. Huang, S.M. Jung, K.K. Ng, Y.C. Chang, and C.H. Lai Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment Gynecol. Oncol. 97 2 2005 652 655
21. E. Epstein, A. Ramirez, L. Skoog, and L. Valentin Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding Acta Obstet. Gynecol. Scand. 80 12 2001 1131 1136
22. K. Niwa, K. Tagami, Z. Lian, K. Onogi, H. Mori, and T. Tamaya Outcome of fertility-preserving treatment in young women with endometrial carcinomas BJOG 112 3 2005 317 320
23. J.L. Brun, J. Belaisch, J. Rivel, and C. Hocke Les hyperplasies endoḿtriales ŕsistant aux progestatifs: alternatives aux traitements traditionnels Gynecol. Obstet. Fertil. 30 3 2002 244 251
24. W.H. Gotlieb, M.E. Beiner, and B. Shalmon Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer Obstet. Gynecol. 102 4 2003 718 725
25. A. Benshushan, O. Paltiel, and A. Brzezinski Ovulation induction and risk of endometrial cancer: a pilot study Eur. J. Obstet. Gynecol. Reprod. Biol. 98 1 2001 53 57